Friday, July 10, 2026

Drug profile · INN

flutamide

flutamide (FLUTAMIN) is a androgen receptor antagonist. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — flutamide
US status
approved
Class
Route
ORAL
Patents
0
Programs
3
Data quality
0.84

Quick answer

flutamide (FLUTAMIN) is a androgen receptor antagonist. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN flutamide
Brand FLUTAMIN
Mechanism Androgen Receptor antagonist
Target Androgen receptor
Route ORAL
Formulation CAPSULE

Mechanism of action

Androgen Receptor antagonist

Primary target: Androgen receptor

Approval history

Authority Status Date
FDA approved
TGA approved

Pipeline programs

  1. CAAA617C12301 Phase 3 · Novartis India · PSMA-positive metastatic hormone-sensitive prostate cancer (
  2. CTRIAL-IE 14-06 Phase 3 · Ningbo Cancer Hospital · Metastatic Prostate Cancer
  3. Casodex® Film-coated Tablets for Localised prostate cancer at hi… Phase 3 · Ningbo Cancer Hospital · Localised prostate cancer at high risk of recurrence

Related & competitor drugs

  1. bicalutamide Androgen Receptor antagonist
  2. danazol Progesterone receptor agonist
  3. nandrolone decanoate Androgen Receptor agonist
  4. testosterone Genito-urinary system and sex hormones (G03)
  5. testosterone cypionate Androgen Receptor agonist
  6. apalutamide Antineoplastic and immunomodulating agents (L02)

Frequently asked questions

What is flutamide?

flutamide (FLUTAMIN) is a androgen receptor antagonist. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for flutamide?

FLUTAMIN is a marketed brand name for flutamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of flutamide?

flutamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.